Merck’s (MRK) Quality is Clear, but Growth Visibility Matters, TD Cowen Notes

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best S&P 500 Dividend Stocks to Buy successful 2026.

On January 20, TD Cowen expert Steve Scala raised Merck & Co., Inc. (NYSE:MRK) terms people to $120 from $100. The steadfast maintained a Hold rating. The expert acknowledged that Merck is simply a beardown and well-run company, but said it whitethorn beryllium hard for the banal to basal retired arsenic a apical pharma prime unless the institution tin present a clearer boost to its semipermanent maturation outlook.

Merck has been trying to fortify that maturation story. On January 12, the institution raised its projections for a caller question of maturation drivers, saying it present expects these newer businesses to bring successful astir $70 cardinal successful gross by the mid-2030s. This comes arsenic the institution speeds up the rollout of further drugs up of expected contention to its blockbuster crab attraction Keytruda.

The updated outlook included higher expectations for respective areas. Merck present believes its cardiometabolic and respiratory treatments could make astir $20 cardinal successful sales, up from a anterior estimation of $15 billion. It besides sharply accrued its forecast for infectious illness drugs, present expecting astir $15 billion, compared with the earlier $5 cardinal estimate.

Meanwhile, Merck & Co., Inc. (NYSE:MRK) and Moderna shared encouraging results connected January 20 tied to their experimental personalized crab vaccine. The companies said the vaccine, erstwhile combined with Keytruda, continued to little the hazard of recurrence oregon decease successful high-risk melanoma patients adjacent 5 years aft attraction began. In the mid-stage proceedings involving patients who had already undergone surgery, the combo reduced the hazard of recurrence oregon decease by 49% aft 5 years, accordant with the beardown three-year information released backmost successful 2023.

Merck & Co., Inc. (NYSE:MRK) is simply a planetary healthcare giant, champion known for its medicine drugs and biologic therapies, vaccines, and carnal wellness products.

While we admit the imaginable of MRK arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Dividend Contenders List: Top 20 Stocks and 12 Most Profitable Dividend Stocks to Buy successful 2026

Disclosure: None.